Brief: United Laboratories International Says IND Application For UBT251 Injection Approved By US FDA
26/09/2023 16:30
Sept 26 (Reuters) - United Laboratories International
Holdings Ltd 3933.HK :
* INVESTIGATIONAL NEW DRUG APPLICATION FOR UBT251 INJECTION
APPROVED BY U.S. FOOD AND DRUG ADMINISTRATION
Further company coverage: 3933.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on United Laboratories International Holdings
See all newsBrief: United Laboratories International Receives Milestone Payment From Novo
Brief: United Laboratories International Says NMPA Accepts Insulin Degludec And Liraglutide Injection Marketing Registration Application
Brief: United Laboratories International Posts HY Profit Attributable RMB 347.6 Million
China's United Laboratories half-year profit drops 82%
Brief: United Laboratories International Expects HY Net Profit RMB 340 Million